Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Methotrexate and cytarabine in adult LCH: High risk, high reward and maintenance free?
Methotrexate and cytarabine in adult LCH: High risk, high reward and maintenance free?
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Jithma P. Abeykoon
,
Ronald S. Go
,
Levi‐Dan Azoulay
,
Julien Haroche
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
British Journal of Haematology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1111/bjh.19903
Similar Items
Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high‐risk Langerhans cell histiocytosis
by: Linda Beneforti, et al.
Published: (2024)
Systemic Xanthogranuloma or Erdheim–Chester disease: A systematic review re‐examining the classification challenge
by: Vyshnavi Rallapalle, et al.
Published: (2026)
Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study
by: Peipei Ye, et al.
Published: (2024)
Duration of anti‐CD20 monoclonal antibody maintenance positively correlates with clinical outcomes in follicular lymphoma patients, supporting adherence to the recommended 2‐year maintenance paradigm
by: Michal Nordkin, et al.
Published: (2025)
Delaying pegaspargase during induction in adults with acute lymphoblastic leukaemia is associated with lower risk of high‐grade hepatotoxicity without adversely impacting outcomes
by: Jose Tinajero, et al.
Published: (2024)